Long-term treatment with the beta-3 adrenoceptor agonist, mirabegron ameliorates detrusor overactivity and restores cyclic adenosine monophosphate (cAMP) levels in obese mice.

Published in:

Neurourology & Urodynamics, 2017, v. 36, n. 6, p. 1511, doi. 10.1002/nau.23171

By:

• Calmasini, Fabiano B.;
• de Oliveira, Mariana G.;
• Alexandre, Eduardo C.;
• da Silva, Fábio H.;
• da Silva, Carmem P.V.;
• Candido, Tuany Z.;
• Antunes, Edson;
• Mónica, Fabíola Z.

Publication type:

Article